Open AccessEvaluating a Novel Hemodialysis Central Venous Catheter Cap in Reducing Bloodstream Infections: A Quality Improvement Initiative
Author(s) -
Steven J. Weiss,
Muhammad Qureshi
Publication year - 2021
Publication title -
international journal of nephrology and renovascular disease
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 0.846
H-Index - 27
ISSN - 1178-7058
DOI - 10.2147/ijnrd.s304605
Subject(s) - medicine , hemodialysis , chlorhexidine , central venous catheter , dialysis , bacteremia , sepsis , central line , bloodstream infection , surgery , catheter , emergency medicine , intensive care medicine , antibiotics , dentistry , microbiology and biotechnology , biology
Central line-associated bloodstream infection (CLABSI) is the second leading cause of death in hemodialysis patients. Patients dialyzed via central venous catheters (CVCs) are more susceptible to vascular access-related bloodstream infection (VRBSI), sepsis, and mortality when compared to patients with other dialysis accesses.